Radioprotective Effects of Dermatan Sulfate in a Preclinical Model of Oral Mucositis—Targeting Inflammation, Hypoxia and Junction Proteins without Stimulating Proliferation

Oral mucositis is the most frequently occurring early side effect of head-and-neck cancer radiotherapy. Systemic dermatan sulfate (DS) treatment revealed a significant radioprotective potential in a preclinical model of oral mucositis. This study was initiated to elucidate the mechanistic effects of...

Full description

Bibliographic Details
Main Authors: Sylvia Gruber, Marlene Arnold, Nilsu Cini, Victoria Gernedl, Sabine Hetzendorfer, Lisa-Marie Kowald, Peter Kuess, Julia Mayer, Susanne Morava, Stephanie Pfaffinger, Andreas Rohorzka, Wolfgang Dörr
Format: Article
Language:English
Published: MDPI AG 2018-06-01
Series:International Journal of Molecular Sciences
Subjects:
Online Access:http://www.mdpi.com/1422-0067/19/6/1684
id doaj-fe19e4da626a4c209ffda15846b9823d
record_format Article
spelling doaj-fe19e4da626a4c209ffda15846b9823d2020-11-25T00:39:58ZengMDPI AGInternational Journal of Molecular Sciences1422-00672018-06-01196168410.3390/ijms19061684ijms19061684Radioprotective Effects of Dermatan Sulfate in a Preclinical Model of Oral Mucositis—Targeting Inflammation, Hypoxia and Junction Proteins without Stimulating ProliferationSylvia Gruber0Marlene Arnold1Nilsu Cini2Victoria Gernedl3Sabine Hetzendorfer4Lisa-Marie Kowald5Peter Kuess6Julia Mayer7Susanne Morava8Stephanie Pfaffinger9Andreas Rohorzka10Wolfgang Dörr11Christian Doppler Laboratory for Medical Radiation Research for Radiation Oncology, Medical University/AKH Vienna, 1090 Vienna, AustriaDepartment of Radiation Oncology, Applied and Translational Radiobiology, Medical University Vienna, 1090 Vienna, AustriaDepartment of Radiation Oncology, Kartal Dr. Lutfi Kırdar Training and Research Hospital, Health Science University, 34722 Istanbul, TurkeyDepartment of Radiation Oncology, Applied and Translational Radiobiology, Medical University Vienna, 1090 Vienna, AustriaDepartment of Radiation Oncology, Applied and Translational Radiobiology, Medical University Vienna, 1090 Vienna, AustriaDepartment of Radiation Oncology, Applied and Translational Radiobiology, Medical University Vienna, 1090 Vienna, AustriaChristian Doppler Laboratory for Medical Radiation Research for Radiation Oncology, Medical University/AKH Vienna, 1090 Vienna, AustriaDepartment of Radiation Oncology, Applied and Translational Radiobiology, Medical University Vienna, 1090 Vienna, AustriaDepartment of Radiation Oncology, Applied and Translational Radiobiology, Medical University Vienna, 1090 Vienna, AustriaDepartment of Radiation Oncology, Applied and Translational Radiobiology, Medical University Vienna, 1090 Vienna, AustriaDepartment of Radiation Oncology, Applied and Translational Radiobiology, Medical University Vienna, 1090 Vienna, AustriaDepartment of Radiation Oncology, Applied and Translational Radiobiology, Medical University Vienna, 1090 Vienna, AustriaOral mucositis is the most frequently occurring early side effect of head-and-neck cancer radiotherapy. Systemic dermatan sulfate (DS) treatment revealed a significant radioprotective potential in a preclinical model of oral mucositis. This study was initiated to elucidate the mechanistic effects of DS in the same model. Irradiation comprised daily fractionated irradiation (5 × 3 Gy/week) over two weeks, either alone (IR) or in combination with daily dermatan sulfate treatment of 4 mg/kg (IR + DS). Groups of mice (n = 5) were sacrificed every second day over the course of 14 days in both experimental arms, their tongues excised and evaluated. The response to irradiation with and without DS was analyzed on a morphological (cell numbers, epithelial thickness) as well as on a functional (proliferation and expression of inflammation, hypoxia and epithelial junction markers) level. The mucoprotective activity of DS can be attributed to a combination of various effects, comprising increased expression of epithelial junctions, reduced inflammation and reduced hypoxia. No DS-mediated effect on proliferation was observed. DS demonstrated a significant mucositis-ameliorating activity and could provide a promising strategy for mucositis treatment, based on targeting specific, radiation-induced, mucositis-associated signaling without stimulating proliferation.http://www.mdpi.com/1422-0067/19/6/1684oral mucositismouse modeldermatan sulfatefractionationinflammationhypoxiacellular junctions
collection DOAJ
language English
format Article
sources DOAJ
author Sylvia Gruber
Marlene Arnold
Nilsu Cini
Victoria Gernedl
Sabine Hetzendorfer
Lisa-Marie Kowald
Peter Kuess
Julia Mayer
Susanne Morava
Stephanie Pfaffinger
Andreas Rohorzka
Wolfgang Dörr
spellingShingle Sylvia Gruber
Marlene Arnold
Nilsu Cini
Victoria Gernedl
Sabine Hetzendorfer
Lisa-Marie Kowald
Peter Kuess
Julia Mayer
Susanne Morava
Stephanie Pfaffinger
Andreas Rohorzka
Wolfgang Dörr
Radioprotective Effects of Dermatan Sulfate in a Preclinical Model of Oral Mucositis—Targeting Inflammation, Hypoxia and Junction Proteins without Stimulating Proliferation
International Journal of Molecular Sciences
oral mucositis
mouse model
dermatan sulfate
fractionation
inflammation
hypoxia
cellular junctions
author_facet Sylvia Gruber
Marlene Arnold
Nilsu Cini
Victoria Gernedl
Sabine Hetzendorfer
Lisa-Marie Kowald
Peter Kuess
Julia Mayer
Susanne Morava
Stephanie Pfaffinger
Andreas Rohorzka
Wolfgang Dörr
author_sort Sylvia Gruber
title Radioprotective Effects of Dermatan Sulfate in a Preclinical Model of Oral Mucositis—Targeting Inflammation, Hypoxia and Junction Proteins without Stimulating Proliferation
title_short Radioprotective Effects of Dermatan Sulfate in a Preclinical Model of Oral Mucositis—Targeting Inflammation, Hypoxia and Junction Proteins without Stimulating Proliferation
title_full Radioprotective Effects of Dermatan Sulfate in a Preclinical Model of Oral Mucositis—Targeting Inflammation, Hypoxia and Junction Proteins without Stimulating Proliferation
title_fullStr Radioprotective Effects of Dermatan Sulfate in a Preclinical Model of Oral Mucositis—Targeting Inflammation, Hypoxia and Junction Proteins without Stimulating Proliferation
title_full_unstemmed Radioprotective Effects of Dermatan Sulfate in a Preclinical Model of Oral Mucositis—Targeting Inflammation, Hypoxia and Junction Proteins without Stimulating Proliferation
title_sort radioprotective effects of dermatan sulfate in a preclinical model of oral mucositis—targeting inflammation, hypoxia and junction proteins without stimulating proliferation
publisher MDPI AG
series International Journal of Molecular Sciences
issn 1422-0067
publishDate 2018-06-01
description Oral mucositis is the most frequently occurring early side effect of head-and-neck cancer radiotherapy. Systemic dermatan sulfate (DS) treatment revealed a significant radioprotective potential in a preclinical model of oral mucositis. This study was initiated to elucidate the mechanistic effects of DS in the same model. Irradiation comprised daily fractionated irradiation (5 × 3 Gy/week) over two weeks, either alone (IR) or in combination with daily dermatan sulfate treatment of 4 mg/kg (IR + DS). Groups of mice (n = 5) were sacrificed every second day over the course of 14 days in both experimental arms, their tongues excised and evaluated. The response to irradiation with and without DS was analyzed on a morphological (cell numbers, epithelial thickness) as well as on a functional (proliferation and expression of inflammation, hypoxia and epithelial junction markers) level. The mucoprotective activity of DS can be attributed to a combination of various effects, comprising increased expression of epithelial junctions, reduced inflammation and reduced hypoxia. No DS-mediated effect on proliferation was observed. DS demonstrated a significant mucositis-ameliorating activity and could provide a promising strategy for mucositis treatment, based on targeting specific, radiation-induced, mucositis-associated signaling without stimulating proliferation.
topic oral mucositis
mouse model
dermatan sulfate
fractionation
inflammation
hypoxia
cellular junctions
url http://www.mdpi.com/1422-0067/19/6/1684
work_keys_str_mv AT sylviagruber radioprotectiveeffectsofdermatansulfateinapreclinicalmodeloforalmucositistargetinginflammationhypoxiaandjunctionproteinswithoutstimulatingproliferation
AT marlenearnold radioprotectiveeffectsofdermatansulfateinapreclinicalmodeloforalmucositistargetinginflammationhypoxiaandjunctionproteinswithoutstimulatingproliferation
AT nilsucini radioprotectiveeffectsofdermatansulfateinapreclinicalmodeloforalmucositistargetinginflammationhypoxiaandjunctionproteinswithoutstimulatingproliferation
AT victoriagernedl radioprotectiveeffectsofdermatansulfateinapreclinicalmodeloforalmucositistargetinginflammationhypoxiaandjunctionproteinswithoutstimulatingproliferation
AT sabinehetzendorfer radioprotectiveeffectsofdermatansulfateinapreclinicalmodeloforalmucositistargetinginflammationhypoxiaandjunctionproteinswithoutstimulatingproliferation
AT lisamariekowald radioprotectiveeffectsofdermatansulfateinapreclinicalmodeloforalmucositistargetinginflammationhypoxiaandjunctionproteinswithoutstimulatingproliferation
AT peterkuess radioprotectiveeffectsofdermatansulfateinapreclinicalmodeloforalmucositistargetinginflammationhypoxiaandjunctionproteinswithoutstimulatingproliferation
AT juliamayer radioprotectiveeffectsofdermatansulfateinapreclinicalmodeloforalmucositistargetinginflammationhypoxiaandjunctionproteinswithoutstimulatingproliferation
AT susannemorava radioprotectiveeffectsofdermatansulfateinapreclinicalmodeloforalmucositistargetinginflammationhypoxiaandjunctionproteinswithoutstimulatingproliferation
AT stephaniepfaffinger radioprotectiveeffectsofdermatansulfateinapreclinicalmodeloforalmucositistargetinginflammationhypoxiaandjunctionproteinswithoutstimulatingproliferation
AT andreasrohorzka radioprotectiveeffectsofdermatansulfateinapreclinicalmodeloforalmucositistargetinginflammationhypoxiaandjunctionproteinswithoutstimulatingproliferation
AT wolfgangdorr radioprotectiveeffectsofdermatansulfateinapreclinicalmodeloforalmucositistargetinginflammationhypoxiaandjunctionproteinswithoutstimulatingproliferation
_version_ 1725292105216032768